Zhi-yong Yang is Head of Discovery Research at ModeX. Previously, he served as the Director of the Vector Core laboratory within the Vaccine Research Center, NIH from 2005 to 2013, during which time he provided scientific leadership guiding the development of novel vaccine candidates and vaccination strategies against HIV-1, Ebola, WNV, SARS-CoV and emerging infectious disease viruses.
Zhi-yong joined Sanofi Global R&D as the Director of the Breakthrough Laboratory in 2013, leading the effort in developing its novel technology platform, and novel biotherapeutics against infectious diseases and cancers using multispecific antibody technologies. In 2020, he joined ModeX Therapeutics to continue his pursuit to develop multispecific Ab technology and nucleic acid delivery technology as well as immunotherapeutics to treat cancers and infectious diseases. He is an author of more than 105 scientific publications.